SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-007757
Filing Date
2022-02-15
Accepted
2022-02-14 21:16:20
Documents
15
Period of Report
2022-02-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea155719-8k_inmedpharma.htm   iXBRL 8-K 40274
2 NEWS RELEASE, DATED FEBRUARY 14, 2022 ea155719ex99-1_inmedpha.htm EX-99.1 114705
3 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
  Complete submission text file 0001213900-22-007757.txt   412703

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20220214.xsd EX-101.SCH 3276
5 XBRL DEFINITION FILE inm-20220214_def.xml EX-101.DEF 26451
6 XBRL LABEL FILE inm-20220214_lab.xml EX-101.LAB 36200
7 XBRL PRESENTATION FILE inm-20220214_pre.xml EX-101.PRE 25109
9 EXTRACTED XBRL INSTANCE DOCUMENT ea155719-8k_inmedpharma_htm.xml XML 4439
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 22636715
SIC: 2834 Pharmaceutical Preparations